Skip to main content
. Author manuscript; available in PMC: 2013 Sep 11.
Published in final edited form as: Circulation. 2012 Sep 11;126(11 Suppl 1):S38–S45. doi: 10.1161/CIRCULATIONAHA.111.083451

Figure 6.

Figure 6

IL-17 modulates ASMC activation. Transient treatment of ASMCs with elastase (5 min) or recombinant IL-17 (10ng/ml) was performed, and cytokine measurement was done after 24hr or 48hr. A significant increase in IL-6, MCP-1, KC, MIP-1α RANTES and TNF-α occurred in elastase-treated or IL-17-treated ASMCs compared to controls. n=8/group; *p<0.05 vs. controls.